This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 May 1;33(13):1422-3.

doi: 10.1200/JCO.2014.60.3548. Epub 2015 Mar 23.

Polypharmacy: geriatric oncology evaluation should become mainstream

Stuart M Lichtman¹

Affiliations

PMID: 25800758
DOI: 10.1200/JCO.2014.60.3548

Editorial

Polypharmacy: geriatric oncology evaluation should become mainstream

Stuart M Lichtman. J Clin Oncol. 2015.

. 2015 May 1;33(13):1422-3.

doi: 10.1200/JCO.2014.60.3548. Epub 2015 Mar 23.

Author

Stuart M Lichtman¹

Affiliation

¹ Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY lichtmas@mskcc.org.

PMID: 25800758
DOI: 10.1200/JCO.2014.60.3548

No abstract available

PubMed Disclaimer

Comment on

Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Nightingale G, et al. J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800766

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.